Sensei Biotherapeutics Inc [SNSE] stock is trading at $0.51, up 17.99%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The SNSE shares have gain 3.73% over the last week, with a monthly amount glided 15.79%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Sensei Biotherapeutics Inc [NASDAQ: SNSE] stock has seen the most recent analyst activity on May 14, 2024, when Stephens initiated its Overweight rating and assigned the stock a price target of $5. Previously, Berenberg downgraded its rating to Hold on July 01, 2021, and kept the price target unchanged to $12. On June 29, 2021, downgrade downgraded it’s rating to Perform and revised its price target to $14 on the stock. Piper Sandler started tracking the stock assigning a Overweight rating and suggested a price target of $25 on March 01, 2021. Oppenheimer initiated its recommendation with a Outperform and recommended $36 as its price target on March 01, 2021. Citigroup started tracking with a Buy rating for this stock on March 01, 2021, and assigned it a price target of $30. In a note dated March 01, 2021, Berenberg initiated an Buy rating and provided a target price of $27 on this stock.
Sensei Biotherapeutics Inc [SNSE] stock has fluctuated between $0.38 and $1.94 over the past year. Currently, Wall Street analysts expect the stock to reach $5.5 within the next 12 months. Sensei Biotherapeutics Inc [NASDAQ: SNSE] shares were valued at $0.51 at the most recent close of the market. An investor can expect a potential return of 978.43% based on the average SNSE price forecast.
Analyzing the SNSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.86% with Operating Profit Margin at -11.41%, Pretax Profit Margin comes in at -10.47%, and Net Profit Margin reading is -10.47%. To continue investigating profitability, this company’s Return on Assets is posted at -0.56, Equity is -0.54 and Total Capital is -0.68. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.4058 points at the first support level, and at 0.3032 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.6852, and for the 2nd resistance point, it is at 0.8620.
Ratios To Look Out For
For context, Sensei Biotherapeutics Inc’s Current Ratio is 7.70. In addition, the Quick Ratio stands at 7.70 and the Cash Ratio stands at 3.52.
